Phreesia, Inc. (NYSE:PHR) COO Sells $480,150.00 in Stock

Phreesia, Inc. (NYSE:PHR) COO Evan Roberts sold 16,005 shares of the business’s stock in a transaction that occurred on Thursday, February 13th. The shares were sold at an average price of $30.00, for a total value of $480,150.00. Following the transaction, the chief operating officer now directly owns 748,302 shares in the company, valued at approximately $22,449,060. This represents a 2.09 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website.

Evan Roberts also recently made the following trade(s):

• On Tuesday, February 18th, Evan Roberts sold 3,519 shares of Phreesia stock. The shares were sold at an average price of $30.06, for a total value of $105,781.14.
• On Monday, January 27th, Evan Roberts sold 10,716 shares of Phreesia stock. The shares were sold at an average price of $27.48, for a total value of $294,475.68.
• On Tuesday, January 21st, Evan Roberts sold 12,749 shares of Phreesia stock. The shares were sold at an average price of $27.31, for a total value of $348,175.19.
• On Wednesday, January 15th, Evan Roberts sold 1,785 shares of Phreesia stock. The shares were sold at an average price of $26.98, for a total value of $48,159.30.
• On Wednesday, January 8th, Evan Roberts sold 2,681 shares of Phreesia stock. The shares were sold at an average price of $27.95, for a total value of $74,933.95.
• On Monday, January 6th, Evan Roberts sold 2,873 shares of Phreesia stock. The shares were sold at an average price of $26.61, for a total value of $76,450.53.

Phreesia Price Performance

Shares of PHR stock opened at $28.49 on Friday. Phreesia, Inc. has a twelve month low of $17.07 and a twelve month high of $30.53. The stock has a market capitalization of $1.66 billion, a price-to-earnings ratio of -19.38 and a beta of 0.96. The stock has a fifty day simple moving average of $27.22 and a two-hundred day simple moving average of $23.80. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.04.

Phreesia (NYSE:PHR) last issued its quarterly earnings data on Monday, December 9th. The company reported ($0.25) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.29) by $0.04. The firm had revenue of $106.80 million during the quarter, compared to analysts’ expectations of $106.33 million. Phreesia had a negative return on equity of 32.78% and a negative net margin of 20.43%. The firm’s quarterly revenue was up 16.6% on a year-over-year basis. During the same period in the prior year, the business posted ($0.58) EPS. On average, analysts predict that Phreesia, Inc. will post -1.1 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on PHR shares. Needham & Company LLC restated a “buy” rating and set a $29.00 price objective on shares of Phreesia in a report on Friday, January 10th. Royal Bank of Canada upgraded Phreesia from a “sector perform” rating to an “outperform” rating and boosted their price objective for the company from $24.00 to $32.00 in a report on Wednesday, January 8th. Robert W. Baird dropped their price objective on Phreesia from $34.00 to $30.00 and set an “outperform” rating for the company in a report on Wednesday, December 11th. Citigroup boosted their price objective on Phreesia from $31.00 to $35.00 and gave the company a “buy” rating in a report on Friday, January 10th. Finally, JMP Securities restated a “market outperform” rating and set a $30.00 price objective on shares of Phreesia in a report on Tuesday, December 10th. Thirteen analysts have rated the stock with a buy rating, According to MarketBeat, Phreesia presently has an average rating of “Buy” and a consensus target price of $31.15.

Institutional Investors Weigh In On Phreesia

Hedge funds have recently made changes to their positions in the stock. Versor Investments LP purchased a new stake in shares of Phreesia during the 3rd quarter worth $694,000. Zacks Investment Management purchased a new stake in shares of Phreesia during the 3rd quarter worth $631,000. State Street Corp lifted its stake in shares of Phreesia by 7.1% during the 3rd quarter. State Street Corp now owns 1,327,586 shares of the company’s stock worth $30,256,000 after purchasing an additional 88,517 shares during the last quarter. Wesbanco Bank Inc. lifted its stake in shares of Phreesia by 76.9% during the 4th quarter. Wesbanco Bank Inc. now owns 46,000 shares of the company’s stock worth $1,157,000 after purchasing an additional 20,000 shares during the last quarter. Finally, Barclays PLC lifted its stake in shares of Phreesia by 83.6% during the 3rd quarter. Barclays PLC now owns 94,929 shares of the company’s stock worth $2,163,000 after purchasing an additional 43,225 shares during the last quarter. 92.10% of the stock is currently owned by hedge funds and other institutional investors.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.